loading image

Surgery for CAD

Arterial Coronary Artery Bypass Grafts

During the last three decades careful studies have clearly shown that coronary artery bypass surgery relieves angina pectoris and other symptoms caused by coronary artery disease and, for some patients, prolongs their lives. However, coronary artery bypass surgery alone does not remove the metabolic causes of coronary artery disease and even after successful operation the occurrence of new obstructions may cause problems as the years ago by. These new obstructions may develop either in the patient’s own coronary arteries (progression of native coronary artery disease) or in bypass grafts, particularly in saphenous vein grafts.

Saphenous vein graft (bypass graft using saphenous vein from the leg)

Within a decade of the development of bypass surgery it became apparent that obstructions could develop in saphenous vein to coronary bypass grafts and that the likelihood of obstructions developing was related to time. Within 5 years of surgery approximately 20% of saphenous vein grafts developed partial or total obstructions, and between 5 and 10 years after operation these processes continued to progress such that by 10 years after operation almost half of saphenous vein grafts were either totally obstructed or showed some angiographic evidence of pathologic changes. Since those early days of cardiac bypass surgery progress has been made in the treatment of patients with vein grafts that decreases the rate of vein graft failure. Taking aspirin early after a cardiac bypass surgery increases the percentage of grafts that are functioning well a year after surgery and, more recently, treatment with HMG-CoA reductase inhibitors, also known as "statin" type drugs, has been shown to have long term benefit. However, the failure of vein grafts over the long term remains a significant problem effecting outcomes after cardiac bypass surgery and it is the single greatest cause of the need for repeat surgery for bypass grafting.


Internal thoracic artery (ITA, also called mammary artery) graft

(bypass graft using left and/or right internal thoracic artery from the chest wall)



Fortunately there have been other bypass grafts available that are resistant to a late failure - internal thoracic (mammary) artery grafts. Internal thoracic artery (ITA) grafts were used from the beginning of bypass surgery although at relatively few centers during the early years. Most commonly the left ITA was left attached at its origin from the left subclavian artery and the distal end was dissected away from the chest wall, swung over, and its distal end was attached with sutures to the side of the left anterior descending (LAD) coronary artery.



In the most common situation the left ITA was used as a graft to the LAD coronary artery and saphenous vein grafts were used from the aorta to the other coronary vessels. Studies of angiograms performed after bypass surgery have shown that not only did the LITA to LAD graft have a more than 90% chance of functioning well early after operation, but that these grafts continued to function well for many years and that even 20 years after operation the development of obstructions in these grafts is extremely uncommon . There are two internal thoracic arteries, one on either side of the sternum (breast bone) and more extensive use of ITA grafts can be accomplished by using the right ITA as an in situ graft (left attached to the right subclavian artery), as a "free" graft from the aorta to the coronary artery, or attached to the left ITA as a composite graft.


The use of both ITAs as bypass grafts is a more complicated operation and there are some patients where this strategy is not appropriate. However, two ITA grafts do produce better outcomes than just one ITA graft for many patients.


Gastroepiploic artery (GEA)



(bypass using artery from the stomach) Because of the success of ITA grafts, surgeons have search for other arterial bypass grafts. The gastroepiploic artery (GEA) is a branch of the blood supply to the stomach (an organ with a very rich blood supply) that has been used as a bypass graft usually to the right coronary artery. This is a technically difficult operation to perform and it has not become a popular bypass graft but it has a high likelihood of good long-term functioning when used in the proper situation and in some patients represents a significant advantage over vein grafts.


Radial artery graft

(bypass graft using artery from inner forearm) The radial artery was used as a bypass graft in the early years of coronary surgery but its use was abandoned for a number of years because of the occurrence of graft occlusions. In the past few years, its use was revived because of the hope that new methods of preparation and drug treatment with antispasm agents might improve the long-term results. The advantage of radial artery grafts is that they are easy to prepare. The hope is that they will be resistant to the development of atherosclerosis, a problem that has plagued vein grafts. However, the long-term (more than 10 years) of outcomes of radial artery grafts are as yet unknown.



Radial artery graft

Our data indicates that the long-term results of radial artery grafts are not as good as those for ITA grafts, in particular we have seen more early graft failures. In fact, radial artery graft patency was not better than for saphenous vein grafts. We continue to recommend and use radial artery grafts, particularly for young patients with hyperlipidemia (high cholesterol or triglycerides) who have a relatively high risk of vein graft failure because of the occurrence of vein graft atherosclerosis. In patients who are 70 years or older we use radial artery grafts more cautiously, mainly when alternative grafts are not available. In addition, a radial graft needs a severe blockage or stenosis in the native artery to be grafted, to have a better chance to be promoted and to stay open.

It is very clear that the internal thoracic arteries are the best bypass grafts that we have. Because not all patients can be completed treated with just the internal thoracic arteries, the search continues to go on for other arterial bypass conduits and/or total arterial revascularization.